CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Scientific Officer sold 1,500 shares at an average $26.36 ($39,545)
- 4 Open-market sale SVP, Chief Scientific Officer sold 11,500 shares at an average $27.42 ($315,278)
- 4 Open-market sale SVP, Chief Financial Officer sold 2,500 shares at $27.42 ($68,543)
- 4 Open-market sale SVP, Chief Scientific Officer sold 10,000 shares at $25.09 ($250,943)
- 4 Open-market sale SVP, Chief Scientific Officer sold 11,500 shares at an average $22.98 ($264,269)
- 4 Open-market sale SVP, Chief Scientific Officer sold 10,000 shares at $25.15 ($251,460)
- 4 Open-market sale SVP, General Counsel sold 10,000 shares at $25.17 ($251,683)
- 4 Open-market sale SVP, Chief Scientific Officer sold 1,500 shares at an average $22.24 ($33,358)
- 4 Open-market sale SVP, General Counsel sold 10,000 shares at an average $22.24 ($222,408)
- 4 Open-market sale SVP, Chief Scientific Officer sold 5,000 shares at an average $22.48 ($112,412)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 10 · 197 filings